Entera Bio Reports Q3 2024 Financial Results and Provides Business Updates
JERUSALEM, Nov. 08, 2024 ( GLOBE NEWSWIRE ) -- Entera Bio Ltd. ( NASDAQ: ENTX ) , ( "Entera" or the "Company" ) a leader in the development of oral peptides and small therapeutic proteins, today reported financial results and key business updates for the quarter ended September 30, 2024.
| Ticker |
Sentiment |
Impact |
|
ENTX
|
Neutral
|
5 %
|
|
META
|
Neutral
|
2 %
|
|
OPK
|
Neutral
|
7 %
|
